ORALLY ADMINISTERED PHARMACEUTICAL AGENT FOR IRON AND MAGNESIUM SUBSTITUTIVE THERAPY

An orally administered pharmaceutical agent that is particularly suited for iron and magnesium substitutive therapy is disclosed. This drug consists of a combination of one or more pharmaceutically and physiologically compatible iron compounds, one or more pharmaceutically and physiologically compat...

Full description

Saved in:
Bibliographic Details
Main Authors CLASSEN; HANS G, HELBIG; JOACHIM
Format Patent
LanguageEnglish
Published 01.09.1992
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An orally administered pharmaceutical agent that is particularly suited for iron and magnesium substitutive therapy is disclosed. This drug consists of a combination of one or more pharmaceutically and physiologically compatible iron compounds, one or more pharmaceutically and physiologically compatible magnesium compounds, and, if the magnesium compounds do not contain any chlorine atoms dissociable in aqueous media and saturating the available magnesium valences, the drug further consists of one or more pharmaceutically and physiologically compatible compounds providing chlorine ions in aqueous media. The iron compounds, magnesium compounds and chlorine ion supplying compounds may be mixed with the conventional pharmaceutical solvents and/or thinners and/or auxiliary matter. Unexpectedly, this drug makes it possible to simultaneously administer magnesium or calcium compounds with iron compounds, without thereby causing reduced iron resorption.
Bibliography:Application Number: US19890323993